NEURO 210: psychiatry

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/35

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

36 Terms

1
New cards

According to DSM-5-TR, what defines a mental disorder?

A syndrome causing significant disturbances in cognition, emotional regulation, or behavior, reflecting dysfunction in psychological/biological/developmental processes.

2
New cards

When is a reaction NOT considered a mental disorder?

If it’s a normal or culturally approved response to loss or stress.

3
New cards

What are psychotherapies designed to address?

A person’s thoughts, behaviors, emotions, and relationships by building insight and changing cognition/behavior.

4
New cards

What do pharmacotherapies usually target?

Specific symptoms, not diagnoses.

5
New cards

What are somatic therapies?

Direct stimulation of neural circuits, e.g., ECT, TMS, DBS, vagal nerve stimulation.

6
New cards

What are DSM-5-TR criteria for MDE?

≥5 symptoms in 2 weeks, must include either:

  • Depressed mood*

  • Anhedonia*
    Plus 3+ of:

  • Appetite/weight changes

  • Sleep issues

  • Psychomotor changes

  • Fatigue

  • Guilt/worthlessness

  • Poor concentration

  • Suicidal ideation

7
New cards

What must be considered when diagnosing MDE?

Symptoms must impair function, occur most days, and not be due to substances or other disorders.

8
New cards

What is the average age of onset for MDD?

25–30 years old.

9
New cards

What is the lifetime prevalence of MDD?

~17%. Women: 10–20%, Men: 5–10%.

10
New cards

How does recurrence risk change with more episodes?

  • 1 episode → 50% risk of second

  • 2 episodes → 80% risk of third

11
New cards

What increases risk of chronicity in MDD?

: Delayed treatment.

12
New cards

How much does family history increase MDD risk?

Risk ↑ 2–3x with first-degree relatives.

13
New cards

What do twin/adoption studies suggest about MDD?

There's a strong genetic component, but environment also plays a role.

14
New cards

What are Adverse Childhood Experiences (ACEs)?

Early negative life events linked to long-term health & mental health risks. Protective factors can buffer the harmful effects

15
New cards

What outcomes are associated with high ACEs?

  • MDD

  • Substance use

  • Chronic illness

  • Lower education/work outcomes

16
New cards

What brain changes are seen in MDD?

Reduced brain volume, especially in:

  • Medial prefrontal cortex

  • Hippocampus

  • Hypothalamus

  • HPA axis

17
New cards

How does chronic stress impact neurogenesis?

cortisol impairs feedback and neurogenesis, making MDD harder to treat.

18
New cards

What is the Biogenic Amine Hypothesis?

Depression = ↓ norepinephrine (NA) and/or serotonin (5-HT) at synapses.

19
New cards

Why is the monoamine hypothesis considered oversimplified?

Depression involves more than NA/5HT — also dopamine, acetylcholine, GABA, glutamate, inflammation, neurogenesis, etc.

20
New cards

What is the average response and remission rate for antidepressants?

Response: 60–80% | Remission: 30–40%. Antidepresants should be continues atleasy 1 year AFTER remission

21
New cards

What risk arises after starting antidepressants?

Possible increased suicidality due to energy increase before mood improves.

22
New cards

How do MAO inhibitors work?

Inhibit monoamine oxidase, preventing breakdown of NA and 5-HT → ↑ NT levels.

23
New cards

How do TCAs (Tricyclic Antidepressants) work?

Block reuptake of NA and 5-HT → more NT at synapses.

24
New cards

How do SSRIs work?

Block reuptake of 5-HT only.

25
New cards

How do SNRIs work?

Block reuptake of both 5-HT and NA.

26
New cards

When is Electroconvulsive Therapy (ECT) used?

For severe, treatment-resistant depression or psychotic depression; mechanism unknown.

27
New cards

When does anxiety become a disorder?

When it causes functional impairment and significant distress.

28
New cards

What is the 12-month prevalence of anxiety disorders?

Around 18%.

29
New cards

What neurochemical systems are involved in anxiety?

Mainly serotonin (5-HT) and noradrenaline (NA).

30
New cards

What brain structures are key in anxiety response?

  • Thalamus: processes sensory input

  • Amygdala: triggers fear

  • Locus ceruleus: spreads fear via NA

  • Hypothalamus: initiates hormonal response

  • Hippocampus: stores emotional memories

31
New cards

What is panic disorder?

Recurrent, unexpected panic attacks with tachycardia, sweating, fear, trembling, etc.

32
New cards

What is social anxiety disorder?

Persistent fear of social situations, leading to avoidance or anxiety attacks.

33
New cards

What are specific phobias?

Clinically significant anxiety in response to specific objects/situations, often with avoidance behavior.

34
New cards

What is Generalized Anxiety Disorder (GAD)?

Excessive worry >6 months with motor tension, autonomic hyperactivity, and hypervigilance.

35
New cards

What are the primary treatments for anxiety disorders?

  • CBT (Cognitive Behavioral Therapy)

  • Antidepressants

  • Benzodiazepines

  • Beta-blockers

36
New cards

How do benzodiazepines work?

Bind to GABA-A receptors, enhance GABA → ↑ Cl⁻ flow = calming effect. ~25% risk of psychological dependence.